Montagu V

Montagu Private Equity is a private equity firm established in 1968 and headquartered in Paris, France, with a significant operational presence in London, United Kingdom. The firm specializes in mid-market buyouts, typically taking majority stakes in companies across various sectors, including technology, healthcare, consumer products, and business services. Montagu operates as an independent investor, having transitioned from its origins as a division of Midland Bank plc. In 2003, its management acquired a controlling interest from HSBC, which retains a minority stake. Montagu focuses on backing management buyouts and supporting growth-stage companies primarily in Northern Europe and has managed several funds targeting diverse sectors, although some initiatives, such as its infrastructure fund, have been discontinued. The firm provides a range of financial, strategic, and operational resources to enhance the development of its portfolio companies.

Pascal Ambrosi

Partner and Member of the Investment Team

Michael Arnez

Investment Director

Ugo Baudry

Investment Director

Laura Bildau

Associate and Member of the Investment Team

Alexander Bokhove

Investment Director

Jan-Paul Boos

Partner and Member of Full Potential Partners Team

Emna Bourkhis

Investment Manager

Barry Broomberg

Partner and Full Potential Partners Team Member

Wim De Bruyne

Partner and Member of the Full Potential Partners Team

Adam Caesari

Investment Director

Raphaël Candelier

Partner, Investment and Member of the Investment Team

Michael Carratt

Partner

Timothy Cochrane

Partner and Head of the Full Potential Partners

Louise Denning

CFO and Partner

Nicole Dixson

Investment Manager

Jolyon Dove

Director

Guillaume Drouet

Investment Director

Antoine Druais

Partner and Member of the Investment Team

Mark Dunfoy

Partner and Member Of Investment Team

Geoffroy Durandet

Partner and Member of the Full Potential Partners Team

Stephan Duwe

Investment Director

Michael Eidenschink Ph.D

Partner and Member of the Full Potential Partners Team

Daniel Fischer

Partner and Member of the Investment Team

Jason Gatenby

Managing Partner and Chair

Neil Graham

Investment Director

Julian Gresvig

Investment Director

Nadine Hennlich

Associate and Member of the Investment team

Sophie Hoas

Partner and Member of the Investment Team

Guillaume Jabalot

Partner and Member of the Investment Team

Henry Johnson

Partner and Member of the Investment Team

Edward Kerr

Investment Manager

Alex Lazare

Director and Member of the Full Potential Partners Team

Christoph Leitner-Dietmaier

Partner and Member of the Investment Team

Thomas Lloyd-Evans

Partner and Member of the dedicated Origination Team

Frank Löhner

Partner and Member of the Investment Team

Atalla Mahmoud

Managing Director

Christophe Maitrier

Principal

Chris Masterson

Chief Executive and Chairman

Frank Meng

Associate and Member of the Investment Team

James Merry

Partner, Investments and Member of Capital Markets Team

Jan Ohlendorf

Investment Manager

Antoine de Peguilhan

Partner and Member of the Investment Team

Thomas Peyer

Principal

Héloïse Pujolle

Investment Director

Claudia Paniker Rumeu

Partner and Member of the Full Potential Partners Team

Adrien Sassi

Partner and Member of the Investment Team

Benedikt Schmidt

Investment Manager

Matthieu Servant

Partner and Member of the Investment Team

Edward Shuckburgh

Managing Partner and CEO

Robin Sie

Investment Director

Artur Sienczewski

Investment Director

Mark Spiteri

Partner, CTO and Member of the Full Potential Partners Team

Jean-Philippe Talmon

Partner and Member of the Full Potential Partners Team

Sophie Tang

Associate and Member of the Investment Team

Hugo Tanner

Investment Director

Lisa Telford

Partner and Member of the Full Potential Partners Team

Ronan Tunney

Partner, Investments and Member of the Investment Team

Katerina Turner-Soukeras

Investment Director

Hanna Weber

Investment Director

Tobias Weltin

Partner and Member of the Investment Team

Hayley Winter

Investment Director

Christian Wolf

Investment Director

Past deals in Luxembourg

Nemera

Acquisition in 2014
Nemera Development S.A. designs, develops, and manufactures drug delivery solutions. The company provides ophthalmic preservative-free multidisc eyedropper; parenteral injectable devices and safety systems; pulmonary inhalation devices; nasal, buccal, and auricular sprays and pumps; and dermal and transdermal dispensers and airless systems. It offers its solutions for the pharmaceutical industry worldwide. Nemera Development S.A. was founded in 2014 and is based in Luxembourg City, Luxembourg with additional plants in Europe and the United States.

BSN medical

Acquisition in 2005
BSN medical is a prominent manufacturer of medical products headquartered in Luxembourg, specializing in Compression Therapy, Wound Care, and Orthopaedics. The company develops a diverse range of high-quality branded products aimed at providing effective solutions for healthcare providers and patients. BSN medical is committed to addressing the needs of the healthcare market, particularly in the treatment of acute, chronic, and challenging wounds. By integrating advanced technology with its extensive product portfolio, the company strives for seamless therapy progression and improved treatment efficiency. BSN medical's approach emphasizes a holistic network of integrated therapy solutions, supporting a continuum of care across various medical disciplines.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.